{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T14:20:29Z","timestamp":1792765229214,"version":"4.5.0"},"reference-count":60,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T00:00:00Z","timestamp":1613952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Status epilepticus (SE) carries an exceedingly high mortality and morbidity, often warranting an aggressive therapeutic approach. Recently, the implementation of a ketogenic diet (KD) in adults with refractory and super-refractory SE has been shown to be feasible and effective. Methods: We describe our experience, including the challenges of achieving and maintaining ketosis, in an adult with new onset refractory status epilepticus (NORSE). Case Vignette: A previously healthy 29-year-old woman was admitted with cryptogenic NORSE following a febrile illness; course was complicated by prolonged super-refractory SE. A comprehensive work-up was notable only for mild cerebral spinal fluid (CSF) pleocytosis, elevated nonspecific serum inflammatory markers, and edematous hippocampi with associated diffusion restriction on magnetic resonance imaging (MRI). Repeat CSF testing was normal and serial MRIs demonstrated resolution of edema and diffusion restriction with progressive hippocampal and diffuse atrophy. She required prolonged therapeutic coma with high anesthetic infusion rates, 16 antiseizure drug (ASD) trials, empiric immunosuppression and partial bilateral oophorectomy. Enteral ketogenic formula was started on hospital day 28. However, sustained beta-hydroxybutyrate levels &gt;2 mmol\/L were only achieved 37 days later following a comprehensive adjustment of the care plan. KD was challenging to maintain in the intensive care unit (ICU) and was discontinued due to poor nutritional state and pressure ulcers. KD was restarted again in a non-ICU unit facilitating ASD tapering without re-emergence of SE. Discussion: There are inconspicuous carbohydrates in commonly administered medications for SE including antibiotics, electrolyte repletion formulations, different preparations of the same drug (i.e., parenteral, tablet, or suspension) and even solutions used for oral care\u2015all challenging the use of KD in the hospitalized patient. Tailoring comprehensive care and awareness of possible complications of KD are important for the successful implementation and maintenance of ketosis.<\/jats:p>","DOI":"10.3390\/jcm10040881","type":"journal-article","created":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T03:34:47Z","timestamp":1613964887000},"page":"881","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Pearls and Pitfalls of Introducing Ketogenic Diet in Adult Status Epilepticus: A Practical Guide for the Intensivist"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7786-7839","authenticated-orcid":false,"given":"Jason B.","family":"Katz","sequence":"first","affiliation":[{"name":"Department of Neurology, Neurocritical Care Division, UF Health-Shands Hospital, University of Florida, Gainesville, FL 32611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7923-3039","authenticated-orcid":false,"given":"Kent","family":"Owusu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yale New Haven Hospital, Yale School of Medicine, New Haven, CT 06520, USA"},{"name":"Care Signature, Yale New Haven Health, New Haven, CT 06510, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilisa","family":"Nussbaum","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yale New Haven Hospital, Yale School of Medicine, New Haven, CT 06520, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Beekman","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yale New Haven Hospital, Yale School of Medicine, New Haven, CT 06520, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A.","family":"DeFilippo","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Services, Yale New Haven Hospital, New Haven, CT 06510, USA"},{"name":"School of Pharmacy, University of Connecticut, Storrs, CT 06269, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily J.","family":"Gilmore","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yale New Haven Hospital, Yale School of Medicine, New Haven, CT 06520, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence J.","family":"Hirsch","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yale New Haven Hospital, Yale School of Medicine, New Haven, CT 06520, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4760-857X","authenticated-orcid":false,"given":"Mackenzie C.","family":"Cervenka","sequence":"additional","affiliation":[{"name":"Department of Neurology, Epilepsy Division, Johns Hopkins Hospital, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8763-5839","authenticated-orcid":false,"given":"Carolina B.","family":"Maciel","sequence":"additional","affiliation":[{"name":"Department of Neurology, Neurocritical Care Division, UF Health-Shands Hospital, University of Florida, Gainesville, FL 32611, USA"},{"name":"Department of Neurology, Yale New Haven Hospital, Yale School of Medicine, New Haven, CT 06520, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,2,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Cervenka, M.C., Wood, S., Bagary, M., Balabanov, A., Bercovici, E., Brown, M.-G., Devinsky, O., Lorenzo, C.D., Doherty, C.P., and Felton, E. (2020). International Recommendations for the Management of Adults Treated with Ketogenic Diet Therapies. Neurol. Clin. Pract.","DOI":"10.1212\/CPJ.0000000000001007"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Kaul, N., Laing, J., Nicolo, J.-P., Nation, J., Kwan, P., and O\u2019Brien, T.J. (2020). Practical considerations for ketogenic diet in adults with super refractory status epilepticus. Neurol. Clin. Pract.","DOI":"10.1212\/CPJ.0000000000001009"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"McDonald, T.J.W., and Cervenka, M.C. (2018). The Expanding Role of Ketogenic Diets in Adult Neurological Disorders. Brain Sci., 8.","DOI":"10.3390\/brainsci8080148"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1212\/WNL.0000000000000151","article-title":"Ketogenic diet for adults in super-refractory status epilepticus","volume":"82","author":"Thakur","year":"2014","journal-title":"Neurology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1212\/WNL.0000000000003690","article-title":"Phase I\/II multicenter ketogenic diet study for adult superrefractory status epilepticus","volume":"88","author":"Cervenka","year":"2017","journal-title":"Neurology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.eplepsyres.2014.09.033","article-title":"Ketogenic diet in pediatric patients with refractory focal status epilepticus","volume":"108","author":"Caraballo","year":"2014","journal-title":"Epilepsy Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/0883073813516192","article-title":"The ketogenic diet as broad-spectrum treatment for super-refractory pediatric status epilepticus: Challenges in implementation in the pediatric and neonatal intensive care units","volume":"30","author":"Cobo","year":"2015","journal-title":"J. Child Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus\u2014Report of the ILAE Task Force on Classification of Status Epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"key":"ref_9","first-page":"537","article-title":"Status epilepticus: Summary","volume":"34","author":"Wasterlain","year":"1983","journal-title":"Adv. Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/BF00967257","article-title":"GABA metabolism in the substantia nigra, cortex, and hippocampus during status epilepticus","volume":"18","author":"Wasterlain","year":"1993","journal-title":"Neurochem. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1523\/JNEUROSCI.0900-05.2005","article-title":"Status epilepticus increases the intracellular accumulation of GABAA receptors","volume":"25","author":"Goodkin","year":"2005","journal-title":"J. Neurosci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1528-1167.2007.01297.x","article-title":"GABA(A) receptor internalization during seizures","volume":"48","author":"Goodkin","year":"2007","journal-title":"Epilepsia"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1523\/JNEUROSCI.3426-07.2008","article-title":"Subunit-specific trafficking of GABA(A) receptors during status epilepticus","volume":"28","author":"Goodkin","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","article-title":"Guidelines for the Evaluation and Management of Status Epilepticus","volume":"17","author":"Brophy","year":"2012","journal-title":"Neurocrit. Care"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/epi.14016","article-title":"Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions","volume":"59","author":"Hirsch","year":"2018","journal-title":"Epilepsia"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1212\/WNL.0000000000001940","article-title":"New-onset refractory status epilepticus: Etiology, clinical features, and outcome","volume":"85","author":"Gaspard","year":"2015","journal-title":"Neurology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.yebeh.2015.05.007","article-title":"Salzburg Consensus Criteria for Non-Convulsive Status Epilepticus\u2014Approach to clinical application","volume":"49","author":"Leitinger","year":"2015","journal-title":"Epilepsy Behav."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.seizure.2018.09.018","article-title":"New onset refractory status epilepticus (NORSE)","volume":"68","author":"Sculier","year":"2019","journal-title":"Seizure"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Curr."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0140-6736(20)30611-5","article-title":"Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): A double-blind, responsive-adaptive, randomised controlled trial","volume":"395","author":"Chamberlain","year":"2020","journal-title":"Lancet"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1097\/CCM.0000000000003869","article-title":"Causes of Death in Status Epilepticus","volume":"47","author":"Hawkes","year":"2019","journal-title":"Crit. Care Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/ane.13302","article-title":"Long-term prognosis related to deep sedation in refractory status Epilepticus","volume":"142","author":"Caronna","year":"2020","journal-title":"Acta Neurol. Scand."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.seizure.2019.09.011","article-title":"A pragmatic approach to intravenous anaesthetics and electroencephalographic endpoints for the treatment of refractory and super-refractory status epilepticus in critical care","volume":"75","author":"Prisco","year":"2020","journal-title":"Seizure"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"106449","DOI":"10.1016\/j.yebeh.2019.106449","article-title":"The anesthetic drug treatment of refractory and super-refractory status epilepticus around the world: Results from a global audit","volume":"101","author":"Ferlisi","year":"2019","journal-title":"Epilepsy Behav."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e2286","DOI":"10.1212\/WNL.0000000000010611","article-title":"Ketamine to treat super-refractory status epilepticus","volume":"95","author":"Alkhachroum","year":"2020","journal-title":"Neurology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.yebeh.2015.05.005","article-title":"Which EEG patterns in coma are nonconvulsive status epilepticus?","volume":"49","author":"Trinka","year":"2015","journal-title":"Epilepsy Behav."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.clineuro.2014.07.038","article-title":"Prognosis and predictors of outcome of refractory generalized convulsive status epilepticus in adults treated in neurointensive care unit","volume":"126","author":"Vooturi","year":"2014","journal-title":"Clin. Neurol Neurosurg."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1093\/brain\/awr215","article-title":"The treatment of super-refractory status epilepticus: A critical review of available therapies and a clinical treatment protocol","volume":"134","author":"Shorvon","year":"2011","journal-title":"Brain"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Annals Neurol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.seizure.2009.10.009","article-title":"Blood beta-hydroxybutyrate correlates better with seizure reduction due to ketogenic diet than do ketones in the urine","volume":"19","author":"Delft","year":"2010","journal-title":"Seizure"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cnp.2017.06.001","article-title":"The role for ketogenic diets in epilepsy and status epilepticus in adults","volume":"2","author":"Williams","year":"2017","journal-title":"Clin. Neurophysiol. Pract."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1111\/j.1528-1167.2010.02703.x","article-title":"Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES)","volume":"51","author":"Nabbout","year":"2010","journal-title":"Epilepsia"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/epi4.12370","article-title":"Systematic review of ketogenic diet use in adult patients with status epilepticus","volume":"5","author":"Mahmoud","year":"2020","journal-title":"Epilepsia Open"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fnins.2019.00005","article-title":"Ketogenic Diet and Epilepsy: What We Know So Far","volume":"13","author":"Meira","year":"2019","journal-title":"Front. Neurosci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1528-1167.2008.01765.x","article-title":"Optimal clinical management of children receiving the ketogenic diet: Recommendations of the International Ketogenic Diet Study Group","volume":"50","author":"Kossoff","year":"2009","journal-title":"Epilepsia"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/epi4.12225","article-title":"Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group","volume":"3","author":"Kossoff","year":"2018","journal-title":"Epilepsia Open"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1055\/s-2004-820992","article-title":"Fatal propofol infusion syndrome in association with ketogenic diet","volume":"35","author":"Baumeister","year":"2004","journal-title":"Neuropediatrics"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1111\/j.1528-1167.2005.00282.x","article-title":"Fasting versus Gradual Initiation of the Ketogenic Diet: A Prospective, Randomized Clinical Trial of Efficacy","volume":"46","author":"Bergqvist","year":"2005","journal-title":"Epilepsia"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1542\/peds.2004-1001","article-title":"Benefits of the Nonfasting Ketogenic Diet Compared With the Initial Fasting Ketogenic Diet","volume":"114","author":"Kim","year":"2004","journal-title":"Pediatrics"},{"key":"ref_40","unstructured":"Ford Flanel, D.E.A. (2017). The Yale-New Haven Hospital (Ynhh) Adult Nutritional Classification and Assessment Manual, Yale New Haven Health System. [24th ed.]."},{"key":"ref_41","unstructured":"Zupec-Kania, B., Abrahams, J., and Pietsch-Escuada, S. (2015). Charlie Foundation: White Paper Proceedings of Ketogenic Diet Therapies Symposium, The Charlie Foundation."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1097\/01.CCM.0000134831.40466.39","article-title":"Relationship of continuous infusion lorazepam to serum propylene glycol concentration in critically ill adults*","volume":"32","author":"Arroliga","year":"2004","journal-title":"Crit. Care Med."},{"key":"ref_43","unstructured":"Cameron, T. (2020, July 01). Carbohydrate Content of Medications. Available online: https:\/\/www.matthewsfriends.org\/keto-therapies\/keto-management\/ketogenic-therapy-anti-epileptic-medications\/carbohydrate-content-medications\/."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1378\/chest.128.3.1674","article-title":"Propylene Glycol Toxicity: A Severe Iatrogenic Illness in ICU Patients Receiving IV Benzodiazepines: A Case Series and Prospective, Observational Pilot Study","volume":"128","author":"Wilson","year":"2005","journal-title":"CHEST"},{"key":"ref_45","first-page":"119","article-title":"Recurrent Metabolic Acidosis during High-dose Midazolam Therapy for Refractory Status Epilepticus","volume":"22","author":"Singh","year":"2018","journal-title":"Indian J. Crit. Care Med. Peer-Rev. Off. Publ. Indian Soc. Crit. Care Med."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Reznik, M.E., Berger, K., and Claassen, J. (2016). Comparison of Intravenous Anesthetic Agents for the Treatment of Refractory Status Epilepticus. J. Clin. Med., 5.","DOI":"10.3390\/jcm5050054"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.seizure.2015.09.007","article-title":"Concomitant lamotrigine use is associated with decreased efficacy of the ketogenic diet in childhood refractory epilepsy","volume":"32","author":"Desadien","year":"2015","journal-title":"Seizure"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/jcpt.12578","article-title":"Effect of ketogenic diet and other dietary therapies on anti-epileptic drug concentrations in patients with epilepsy","volume":"42","author":"Heo","year":"2017","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ajic.2017.12.001","article-title":"Healthcare-associated infections in the neurological intensive care unit: Results of a 6-year surveillance study at a major tertiary care center","volume":"46","author":"Abulhasan","year":"2018","journal-title":"Am. J. Infect. Control"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0002-8223(01)00021-9","article-title":"Avoid Unnecessary Drug-Related Carbohydrates for Patients Consuming the Ketogenic Diet","volume":"101","author":"Mcghee","year":"2001","journal-title":"J. Am. Diet. Assoc."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"428","DOI":"10.4037\/ajcc2009792","article-title":"Chlorhexidine, Toothbrushing, and Preventing Ventilator-Associated Pneumonia in Critically Ill Adults","volume":"18","author":"Munro","year":"2009","journal-title":"Am. J. Crit. Care"},{"key":"ref_52","unstructured":"Zupec-Kania, B., and Foundation, C. (2020, August 01). Appendix 3: Minimising the Carbohydrate Content of Medications on Theketogenicdiet. Available online: https:\/\/media.gosh.nhs.uk\/documents\/APPENDIX_3_Minimising_the_carbohydrate_content_of_medications_on_the_ketogenic_diet.pdf."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1528-1167.2008.01827.x","article-title":"Long-term management of the ketogenic diet: Seizure monitoring, nutrition, and supplementation","volume":"49","author":"Zupanc","year":"2008","journal-title":"Epilepsia"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s12028-018-0653-2","article-title":"The Feasibility, Safety and Effectiveness of a Ketogenic Diet for Refractory Status Epilepticus in Adults in the Intensive Care Unit","volume":"30","author":"Francis","year":"2019","journal-title":"Neurocrit. Care"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1177\/193229680900300604","article-title":"Hyperglycemia in Critical Illness: A Review","volume":"3","author":"David","year":"2009","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/1941406411419657","article-title":"Enteral and Parenteral Applications of Ketogenic Diet Therapy","volume":"3","author":"Aldaz","year":"2011","journal-title":"ICAN Infant Child Adolesc. Nutr."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.eplepsyres.2011.04.003","article-title":"Is there an ideal way to discontinue the ketogenic diet?","volume":"95","author":"Worden","year":"2011","journal-title":"Epilepsy Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1528-1167.2006.00911.x","article-title":"Discontinuing the Ketogenic Diet in Seizure-Free Children: Recurrence and Risk Factors","volume":"48","author":"Martinez","year":"2007","journal-title":"Epilepsia"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.0013-9580.2004.10004.x","article-title":"Early- and Late-onset Complications of the Ketogenic Diet for Intractable Epilepsy","volume":"45","author":"Kang","year":"2004","journal-title":"Epilepsia"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.pediatrneurol.2015.01.009","article-title":"Protein-Losing Enteropathy as a Rare Complication of the Ketogenic Diet","volume":"52","author":"Moriyama","year":"2015","journal-title":"Pediatric Neurol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/4\/881\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:27:36Z","timestamp":1760160456000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/4\/881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,22]]},"references-count":60,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["jcm10040881"],"URL":"https:\/\/doi.org\/10.3390\/jcm10040881","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,22]]}}}